CSIMarket Company Name, Ticker, Competitors, else..
 
Grail Inc   (NASDAQ: GRAL)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Grail Inc's Suppliers Performance

GRAL's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
GRAL Costs vs Sales of Suppliers Growth Grail Inc's cost of sales deteriorated by -36.53 % year on year, relative to one quarter ago cost of sales fell by -21.8 % in Q1.

• More on GRAL Suppliers



Grail Inc's cost of sales deteriorated by -36.53 % year on year, compare to one quarter ago cost of sales fell by -21.8 % in Q1.

• More on GRAL Suppliers




Grail Inc's Comment on Supply Chain


GRAIL relies on sole suppliers for certain critical materials used in its products and services. Illumina, Inc. is the sole supplier of sequencers and specific laboratory reagents. Madison, which acquired Streck, Inc. in 2023, is the sole supplier of tubes used for sample collection. Twist Biosciences Corporation is the sole supplier of DNA probes. GRAIL maintains supply agreements with these companies and implements a risk-based safety stock strategy to support continuous laboratory operations throughout the year. The company utilizes standard commercial carriers for sample delivery. The supply agreement with Illumina includes a royalty payment structure based on net sales in the oncology field, featuring specific terms and anti-stacking provisions.

Grail Inc's Comment on Supply Chain


GRAIL relies on sole suppliers for certain critical materials used in its products and services. Illumina, Inc. is the sole supplier of sequencers and specific laboratory reagents. Madison, which acquired Streck, Inc. in 2023, is the sole supplier of tubes used for sample collection. Twist Biosciences Corporation is the sole supplier of DNA probes. GRAIL maintains supply agreements with these companies and implements a risk-based safety stock strategy to support continuous laboratory operations throughout the year. The company utilizes standard commercial carriers for sample delivery. The supply agreement with Illumina includes a royalty payment structure based on net sales in the oncology field, featuring specific terms and anti-stacking provisions.







GRAL's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Grail Inc 3,225.67 156.12 -395.33 910
SUBTOTAL 0.00 0.00 0.00 -


Sources: Grail Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Grail Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.